Cargando…

Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians

Background: Due to poor diabetes self-management awareness as well as heavy patient burden, management of diabetes in India is challenging for clinicians. Digital therapeutics platforms provide accessible and cost-efficient care through evidence-based guidance for lifestyle and behavioural modificat...

Descripción completa

Detalles Bibliográficos
Autores principales: Singal, Arbinder, Verma, Ritika, Khader, Mohammed Abdul, Tanna, Snehal, Lakhani, Om, Chavan, Ravi, das, Rabindra, Modi, Alok, Patange, Sonali, Ranadive, Ruchira, Malde, Forum, Guntur, Saimala
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067812/
http://dx.doi.org/10.4103/2230-8210.342262
_version_ 1784700090366033920
author Singal, Arbinder
Verma, Ritika
Khader, Mohammed Abdul
Tanna, Snehal
Lakhani, Om
Chavan, Ravi
das, Rabindra
Modi, Alok
Patange, Sonali
Ranadive, Ruchira
Malde, Forum
Guntur, Saimala
author_facet Singal, Arbinder
Verma, Ritika
Khader, Mohammed Abdul
Tanna, Snehal
Lakhani, Om
Chavan, Ravi
das, Rabindra
Modi, Alok
Patange, Sonali
Ranadive, Ruchira
Malde, Forum
Guntur, Saimala
author_sort Singal, Arbinder
collection PubMed
description Background: Due to poor diabetes self-management awareness as well as heavy patient burden, management of diabetes in India is challenging for clinicians. Digital therapeutics platforms provide accessible and cost-efficient care through evidence-based guidance for lifestyle and behavioural modifications. Aim and Objectives: To evaluate the effectiveness of Diabefly(®) digital therapeutics platform for glycemic control among people with type 2 diabetes. Results: De-identified data of 144 participants referred by physicians (mean age: 46.42 years, 54.54 % females) on the 90 days Diabefly(®) program was analyzed. A mean significant reduction in HbA1C was observed by 1.56% (P< 0.001) from baseline 8.59%. Similarly, mean weight and BMI significantly reduced by 2.39 kg and 0.84 kg/m(2) (P<0.001 for both) from a baseline of 75.63 kg and 27.34 kg/m(2) respectively. Complete FBS and PPBS readings were provided by 56 and 39 participants respectively. A mean reduction in FBS and PPBS was observed by 53.93 mg/dL and 99.25 mg/dl (P < 0.001 for both) from a baseline of 168.2 mg/dL and 234.7 mg/dl respectively. Conclusion: Significant reduction in HbA1c, weight, BMI, FBS and PPBS was observed after participation in the Diabefly(®) program. The study thus showed significant improvement in glycemic control in people with diabetes after participation.
format Online
Article
Text
id pubmed-9067812
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Wolters Kluwer - Medknow
record_format MEDLINE/PubMed
spelling pubmed-90678122022-05-05 Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians Singal, Arbinder Verma, Ritika Khader, Mohammed Abdul Tanna, Snehal Lakhani, Om Chavan, Ravi das, Rabindra Modi, Alok Patange, Sonali Ranadive, Ruchira Malde, Forum Guntur, Saimala Indian J Endocrinol Metab Abstracts … Esicon 2021 Background: Due to poor diabetes self-management awareness as well as heavy patient burden, management of diabetes in India is challenging for clinicians. Digital therapeutics platforms provide accessible and cost-efficient care through evidence-based guidance for lifestyle and behavioural modifications. Aim and Objectives: To evaluate the effectiveness of Diabefly(®) digital therapeutics platform for glycemic control among people with type 2 diabetes. Results: De-identified data of 144 participants referred by physicians (mean age: 46.42 years, 54.54 % females) on the 90 days Diabefly(®) program was analyzed. A mean significant reduction in HbA1C was observed by 1.56% (P< 0.001) from baseline 8.59%. Similarly, mean weight and BMI significantly reduced by 2.39 kg and 0.84 kg/m(2) (P<0.001 for both) from a baseline of 75.63 kg and 27.34 kg/m(2) respectively. Complete FBS and PPBS readings were provided by 56 and 39 participants respectively. A mean reduction in FBS and PPBS was observed by 53.93 mg/dL and 99.25 mg/dl (P < 0.001 for both) from a baseline of 168.2 mg/dL and 234.7 mg/dl respectively. Conclusion: Significant reduction in HbA1c, weight, BMI, FBS and PPBS was observed after participation in the Diabefly(®) program. The study thus showed significant improvement in glycemic control in people with diabetes after participation. Wolters Kluwer - Medknow 2022-03 /pmc/articles/PMC9067812/ http://dx.doi.org/10.4103/2230-8210.342262 Text en Copyright: © 2022 Indian Journal of Endocrinology and Metabolism https://creativecommons.org/licenses/by-nc-sa/4.0/This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
spellingShingle Abstracts … Esicon 2021
Singal, Arbinder
Verma, Ritika
Khader, Mohammed Abdul
Tanna, Snehal
Lakhani, Om
Chavan, Ravi
das, Rabindra
Modi, Alok
Patange, Sonali
Ranadive, Ruchira
Malde, Forum
Guntur, Saimala
Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
title Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
title_full Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
title_fullStr Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
title_full_unstemmed Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
title_short Abstract 137: Improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
title_sort abstract 137: improved glycemic control among people with type 2 diabetes with a digital therapeutics approach in collaboration with clinicians
topic Abstracts … Esicon 2021
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9067812/
http://dx.doi.org/10.4103/2230-8210.342262
work_keys_str_mv AT singalarbinder abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT vermaritika abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT khadermohammedabdul abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT tannasnehal abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT lakhaniom abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT chavanravi abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT dasrabindra abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT modialok abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT patangesonali abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT ranadiveruchira abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT maldeforum abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians
AT guntursaimala abstract137improvedglycemiccontrolamongpeoplewithtype2diabeteswithadigitaltherapeuticsapproachincollaborationwithclinicians